Because the number of ccRCC spots with negative LPCAT1 IHC staining was limited, we divided the cohort of 150 ccRCC cases into three groups based on LPCAT1 IHC intensity: negative/weak (-/+), moderate (++) and intense (+++). This evidence concerns the gene LPCAT1 and nonpapillary renal cell carcinoma.